XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

138 hedge funds and large institutions have $808M invested in Intersect ENT, Inc in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 42 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$24.2M
Puts
$17.2M
Net Calls
Net Calls Change

Top Buyers

1 +$32.4M
2 +$26.6M
3 +$19.6M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.23M
5
BlackRock
BlackRock
New York
+$8.54M

Top Sellers

1 -$36.7M
2 -$28.1M
3 -$15.1M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$14.2M
5
Renaissance Technologies
Renaissance Technologies
New York
-$10.4M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$974K
77
$949K
78
$949K
79
$868K
80
$863K
81
$859K
82
$808K
83
$802K
84
$779K
85
$772K
86
$658K
87
$571K
88
$566K
89
$555K
90
$530K
91
$507K
92
$437K
93
$429K
94
$402K
95
$391K
96
$367K
97
$344K
98
$343K
99
$317K
100
$297K